IdenTrust Inc. Logo
Home | Login | Contact Us  

  
AT A GLANCE COMPANY PROFILE EXECUTIVE TEAM BOARD OF DIRECTORS IN THE NEWS EVENTS
PRESS RELEASES


Company > In The News > Press Releases

NEW YORK, FEB. 10, 2005
Identrus and SAFE-BioPharma, LLC Announce Agreement to Collaborate on Interoperability and Marketing
Identrus™, a global provider of trusted identity solutions, and SAFE-BioPharma, LLC, an organization dedicated to managing an electronic signature standard for worldwide use by the biopharmaceutical industry, today announced that the companies have reached an agreement under which SAFE (Secure Access for Everyone) and Identrus will collaborate to assure interoperability of digital credentials issued by SAFE Members and by Identrus Participants accredited by SAFE, and Identrus will exclusively market implementations of the SAFE Standard outside the biopharmaceutical industry.

Under the agreement, SAFE-BioPharma and Identrus will cross license certain intellectual property, including business and technical specifications related to electronic identity and digital signatures. The agreement expands on previous discussions in which Identrus Participant financial institutions are working with SAFE-BioPharma to issue Identrus digital credentials to SAFE-BioPharma sponsors and identified end users. SAFE-BioPharma accredits certified issuers to provide credentials compliant with SAFE standards to support strong authentication and legally enforceable digital signatures across healthcare industry business applications.

Both Identrus and SAFE-BioPharma seek to reduce the cost of electronic identity management through the standardization of legal, business and technical policies. Under this agreement, digital credentials, issued by SAFE accredited Identrus Participants and by pharmaceutical companies that are Members of SAFE, will be seamlessly interoperable within the SAFE user community.

"The Identrus partnership allows Identrus to extend the SAFE concept, model, and standards across multiple industries beyond biopharmaceuticals." said Gary Secrest, director of World Wide Information Security at Johnson & Johnson and Chairman of the SAFE initiative. "As other industries begin to use the SAFE standard approach we anticipate an increased supply of commercially ready, SAFE-enabled applications; making digital credentials more ubiquitous and cost efficient for our sponsors, and for other user communities."

"SAFE is a user community with applications requiring digital credentials. Identrus is a community of suppliers of digital credentials seeking users and applications. This collaboration creates enhanced synergies between these communities. It will stimulate demand for Identrus credentials, both within the SAFE biopharmaceutical community, and in other industries." said Karen Wendel, CEO, Identrus LLC. "Identrus will be aggressively marketing new implementations of the SAFE concept using Identrus credentials into other industry communities."

The SAFE digital credential standard was developed to simplify business partner interactions across the biopharmaceutical industry through a policy and technology framework for digital signature and authentication. This allows the SAFE community to eliminate the need for multiple identity credentials when interacting with each other and business partners. Going forward, Identrus, its member banks, and SAFE look forward to a strong partnership as this concept is applied to other industries. "What is clear," added Ms. Wendel, "is that Identrus and SAFE-BioPharma have a common goal: to make interoperable digital credentials the preferred credential approach for commercial applications across a base of multiple industries."

About Identrus
Identrus™ is a global solutions company that secures interactions where identity is critical. As the only government regulated, bank-built identity company, Identrus provides a worldwide network for trusted identity credentials based on global standards. Identrus' proven solutions provide a legally and technologically interoperable environment for using identities. The Identrus platform provides the legal and technical infrastructure for financial institutions, governments and commercial entities to effectively manage the risks associated with identity authentication and enables these organizations to develop business applications and value-added services for their customers. Identrus partners with systems integrators, software developers, smart card and token providers, as well as experts on identity management, security and fraud to help organizations achieve greater application security and meet their e-business objectives. Identrus membership consists of more than 55 of the world's leading financial institutions spanning 160 countries. Additional information about the company is available at www.identrust.com.

About The SAFE Standard
The SAFE (Secure Access for Everyone) coalition was formed in 2003 to develop SAFE as a bio-pharmaceutical industry trust standard. The mission of SAFE is to deliver unique electronic identity credentials for legally enforceable and regulatory compliant electronic signatures across the global biopharmaceutical environment. The SAFE standard is intended for business-to-business, and business-to-regulator transactions. SAFE-BioPharma, LLC offers a variety of membership options for organizations seeking to join or leverage the SAFE standard.

For more information, visit www.safe-biopharma.org.
Press Contact

Schwartz Communications, Inc.
Rebecca Krueger
+1 415-512-0770

Identrust@schwartz-pr.com



RELATED CONTENT
IdenTrust Company Demo


PRESS RELEASES
2007
2006
2005
2004
Archives
Web Seminars


IDENTRUST IN THE NEWS
2007
2006
 © 2008 IdenTrust Inc. All Rights Reserved    Home | Contact Us | Legal Policies IdenTrust